- Home
- Anti Malarial drug
WHO ends hydroxychloroquine trial for COVID-19
Scientists find no survival benefit of treating COVID-19 patients with HCQ
Lancet retracts study that linked HCQ to increased death risk
WHO approves trial of HCQ for potential COVID-19 treatment
WHO suspends COVID-19 trials of HCQ over safety issues
Hydroxychloroquine linked to increased risk of death in hospitalized Covid-19 patients: Study
Covid-19: West Bengal to ramp up the production of Hydroxychloroquine
India to export HCQ only to foreign govts and not to pvt companies: Sources
Latest Additions
Youth detained for Facebook threat to BJP MLA in Nashik
NE’s integration with rest of India happened under Modi govt: BJP chief Nadda
Congress spokesperson booked for alleged hate speech
BJP files complaint with EC against Sowmya Reddy, others for alleged violation of poll code
Siddaramaiah slams BJP candidate for visiting house of alleged police recruitment scam kingpin